Back to FMR LLC FMR LLC

CYTKCYTK
28 quarters

Position history for FMR LLCFMR LLC's holdings in CYTOKINETICS INC

Yes. FMR holds 5,031,782 shares of CYTK (Cytokinetics), worth $428.7M, as of its Q2 2026 13F filing. It reduced the position by 5,691,358 shares (-53.1%) from Q1 2026. FMR has held CYTK in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$428.7M

Current Shares

5M

Total Value Change

+$409.5M

Total Shares Change

+3.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5M
-53.1%
$428.7M0.0%$85.19
0
2026-Q1
Decreased
10.7M
-16.3%
$706.8M0.0%$65.91
0
2025-Q4
Decreased
12.8M
-2.2%
$813.8M0.0%$63.54
0
2025-Q3
Increased
13.1M
+16.2%
$719.5M0.0%$54.96
37
2025-Q2
Increased
11.3M
+9.2%
$372.3M0.0%$33.04
34
2025-Q1
Decreased
10.3M
-4.4%
$414.6M0.0%$40.19
0
2024-Q4
Decreased
10.8M
-10.8%
$507.8M0.0%$47.04
0
2024-Q3
Increased
12.1M
+5.0%
$638.6M0.0%$52.80
33
2024-Q2
Increased
11.5M
+5.7%
$624.3M0.0%$54.18
33
2024-Q1
Decreased
10.9M
-16.2%
$764.3M0.1%$70.11
0
2023-Q4
Increased
13M
+8.5%
$1.1B0.1%$83.49
35
2023-Q3
Decreased
12M
-1.4%
$353.2M0.0%$29.46
0
2023-Q2
Decreased
12.2M
-5.5%
$396.8M0.0%$32.62
0
2023-Q1
Decreased
12.9M
-3.7%
$452.7M0.0%$35.19
0
2022-Q4
Increased
13.4M
+3.7%
$612.2M0.1%$45.82
33
2022-Q3
Increased
12.9M
+0.7%
$624.5M0.1%$48.45
32
2022-Q2
Increased
12.8M
+0.8%
$503.1M0.1%$39.29
31
2022-Q1
Increased
12.7M
+1.3%
$467.7M0.0%$36.81
32
2021-Q4
Increased
12.5M
+0.4%
$571.6M0.0%$45.58
31
2021-Q3
Increased
12.5M
+47.1%
$446.2M0.0%$35.74
43
2021-Q2
Increased
8.5M
+121.0%
$168M0.0%$19.79
49
2021-Q1
Increased
3.8M
+270.3%
$89.4M0.0%$23.26
48
2020-Q4
Decreased
1M
-69.1%
$21.6M0.0%$20.78
0
2020-Q3
Decreased
3.4M
-4.4%
$72.6M0.0%$21.65
0
2020-Q2
Increased
3.5M
+19.6%
$82.7M0.0%$23.57
35
2020-Q1
Increased
2.9M
+64.5%
$34.6M0.0%$11.79
42
2019-Q4
Increased
1.8M
+6.0%
$18.9M0.0%$10.61
30
2019-Q3
First report
1.7M
-
$19.2M0.0%$11.38
0

Other major holders of CYTK: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used